Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 32
Inquire Before Buying

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Hypertropic Cardiomyopathy – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypertropic Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertropic Cardiomyopathy. Hypertropic Cardiomyopathy – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Hypertropic Cardiomyopathy.
- A review of the Hypertropic Cardiomyopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypertropic Cardiomyopathy pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Hypertropic Cardiomyopathy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hypertropic Cardiomyopathy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hypertropic Cardiomyopathy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hypertropic Cardiomyopathy 7
Hypertropic Cardiomyopathy Therapeutics under Development by Companies 9
Hypertropic Cardiomyopathy Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Hypertropic Cardiomyopathy Therapeutics - Products under Development by Companies 13
Hypertropic Cardiomyopathy Therapeutics - Products under Investigation by Universities/Institutes 14
Companies Involved in Hypertropic Cardiomyopathy Therapeutics Development 15
Novartis AG 15
Hypertropic Cardiomyopathy - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
ARRY-162 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
perhexiline - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
diltiazem hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
atorvastatin calcium - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
losartan potassium - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
losartan potassium - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Number of Products Under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Products under Development by Companies, H2 2012 13
Products under Investigation by Universities/Institutes, H2 2012 14
Novartis AG, H2 2012 15
Assessment by Monotherapy Products, H2 2012 16
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Stage and Molecule Type, H2 2012 20
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30

List of Figures
Number of Products under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Assessment by Monotherapy Products, H2 2012 16
Assessment by Route of Administration, H2 2012 17
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Molecule Type, H2 2012 19
Assessment by Stage and Molecule Type, H2 2012 20

  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • OpportunityAnalyzer: Acromegaly and Gigantism – Opportunity Analysis and Forecast to 2018
    Published: 18-Dec-2014        Price: US $7995 Onwards        Pages: 161
    GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% and generating around 68% of global sales in 2018, the US market will experience twice the rate of growth of the 5EU market. Two major trends are visible among the pipeline drugs and research and d......
  • Russia: Eyeglasses (Optics) Market. Analysis and Forecast to 2017
    Published: 18-Dec-2014        Price: US $3281 Onwards        Pages: 257
    The report provides current information about the Russian Optical Glasses Market as of January 2012 The objectives of this market research report are to describe the state of the Russian sunglasses and eyeglasses (optics) market and to provide current information on volumes of production, exports, imports, consumption and market conditions, changes that occurred in 2010 and 2011, As well as to build a forecast of the industry in the medium term for the period before 2017 The optics market ......
  • 2014 Market Research Report on Global Disposable Syringe Industry
    Published: 17-Dec-2014        Price: US $2600 Onwards        Pages: 178
    This is a professional and depth research report on Global Disposable Syringe industry For overview analysis, the report introduces Disposable Syringe basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Disposable Syringe markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research o......
  • 2014 Market Research Report on Global Vitamin K3 Industry
    Published: 17-Dec-2014        Price: US $2600 Onwards        Pages: 180
    This is a professional and depth research report on Global Vitamin K3 industry For overview analysis, the report introduces Vitamin K3 basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Vitamin K3 markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of dif......
  • Bahrain Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 101
    BMI View: Our outlook for Bahrain's pharmaceutical and healthcare sector remains strong, with the government announcing the development and expansion of health centres across the country in addition to several preventive health projects planned. Despite recent price cuts negatively impacting the market in the short term, we believe an ageing population, increasing chronic disease burden and robust economic growth will drive medicine demand for many years to come. Headline Expenditure Projections......
  • Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade. Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicable diseases, this represents an epidemiological transition that will present new opportunities for pharmaceutical companies. Headline Expenditure Projections ? Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4% in local currency terms and +11.9% in US dollar......
  • Nurse Call System (NCS) Market in the US 2015-2019
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 72
    Nurse Call System is a communication solution used in healthcare facilities, which enables patients to alert caregivers in case of any routine need or emergency assistance. It serves as the core component of healthcare communication platform and is an innovative, reliable service that alerts the nursing staff through visual and audio signals. It provides the location of the patient in need and indicates the urgency of the call, regardless of the patient's location in the hospital or care center.......
  • Belarus Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 87
    BMI View: The Belarusian market will suffer from the impact of depreciation and economic instability as the country's economy becomes ever more reliant on Russian loans to function. Furthermore, wage growth mandated by the government will become unsustainable, threatening to dampen internal consumption. Belarus will present little reward for high risk for most pharmaceutical companies in the region. Headline Expenditure Projections Pharmaceuticals: BYR8,927bn in 2013 (USD1.00bn) to BYR11,490bn (......
  • Global Rehabilitation Robotics Market 2015-2019
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 49
    Rehabilitation robots play an important role in improving a patient's functional recovery. Stroke is a global problem, and it is the main cause of disability in most western countries. Rehabilitation robots are used as therapy aids and the potential benefit of robotic therapy is that it can treat a larger number of patients under the supervision of a single therapist. In other words, rehabilitation robots work as a therapeutic tool for optimizing and maximizing clinical effectiveness of a therap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs